Publications
See a complete PubMed list of publications by Stephen J. Freedland, MD.
Selected Key Publications
- Freedland SJ. Smoking and death from prostate cancer death [published online ahead of print May 24, 2018]. JAMA Onc. https://jamanetwork.com/journals/jamaoncology/fullarticle/2682184.
- Branche BL, Howard LE, Moreira DM, Roehrborn C, Castro-Santamaria R, Andriole GL, Hopp ML, Freedland SJ. Sleep problems are associated with development and progression of lower urinary tract symptoms: Results from REDUCE. J Urol. 2018 Feb;199(2):536-542. https://www.jurology.com/article/S0022-5347(17)77428-9/fulltext.
- Jamnagerwalla J, Howard LE, Allott EH, Vidal AC, Moreira DM, Castro-Santamaria R, Andriole GL, Freeman MR, Freedland SJ. Serum cholesterol and risk of high-grade prostate cancer: results from the REDUCE study. Prostate Cancer Prostatic Dis. 2017 Dec 27. [Epub ahead of print]. http://www.nature.com/articles/s41391-017-0030-9.
- Zhao SG, Chang SL, Erho N, Yu M, Lehrer J, Alshalalfa M, Speers C, Cooperberg MR, Kim W, Ryan CJ, Den RB, Freedland SJ, et al. Associations of luminal and basal subtyping of prostate cancer with prognosis and response to androgen deprivation therapy. JAMA Onc. 2017 Dec;3(12):1663-1672. https://jamanetwork.com/journals/jamaoncology/article-abstract/2626510.
- Lin PH, Aronson WJ, and Freedland SJ. An update of research evidence on nutrition and prostate cancer. Urol Oncol. 2017 Nov 2. pii: S1078-1439(17)30536-7. https://www.urologiconcology.org/article/S1078-1439(17)30536-7/fulltext.
- Freedland SJ. Are you what you eat or what your mother ate or both? Cancer Prev Res. 2017 Oct;10(10):551-552. https://aacrjournals.org/cancerpreventionresearch/article/10/10/551/112909/Are-You-What-You-Eat-or-What-Your-Mother-Ate-or.
- Xiao J, Howard L, Wan J, Wiggins E, Vidal A, Cohen P, Freedland SJ. Low circulating levels of the mitochondrial-peptide hormone SHLP2: novel biomarker for prostate cancer risk. Oncotarget. 2017 Aug 10;8(55):94900-94909.
http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path=20134. - McGinley K, Sun X, Howard LE, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Freedland SJ. Characterization of a “low-risk” cohort of grade group 2 prostate cancer patients: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Int J Urol. 2017 Aug;24(8):611-617. https://onlinelibrary.wiley.com/doi/abs/10.1111/iju.13387.
- Guerrios-Rivera L, Howard L, Frank J, De Hoedt A, Beverly D, Grant DJ, Hoyo C, Freedland SJ. Is BMI the best adiposity measure for prostate cancer risk? Results from a Veterans Affairs biopsy cohort. Urology. 2017 Jul;105:129-135. https://www.goldjournal.net/article/S0090-4295(17)30347-3/fulltext.
- Allott EH, Macias E, Sanders S, Knudsen BS, Thomas GV, Hursting SD, Freedland SJ. Impact of carbohydrate restriction in the context of obesity on prostate tumor growth in the Hi-Myc transgenic mouse model. Prostate Cancer Prostatic Dis. 2017 Jun;20(2):165-171. https://www.nature.com/articles/pcan201673.
- Allott EH, Howard LE, Vidal AC, Moreira DM, Castro-Santamaria R, Andriole GL, Freedland SJ. Statin use, serum lipids and prostate inflammation in men with a negative prostate biopsy: results from the REDUCE trial. Cancer Prev Res. (Phila). 2017 Jun;10(6):319-326. https://aacrjournals.org/cancerpreventionresearch/article/10/6/319/46628/Statin-Use-Serum-Lipids-and-Prostate-Inflammation
- Freedland SJ, Vidal AC, Howard LE, Terris MK, Cooperberg MR, Amling CL, Kane CJ, Aronson WJ. Race and risk of metastases and survival after radical prostatectomy: results from the SEARCH database. Cancer. 2017;123(21):4199-4206. https://www.onlinelibrary.wiley.com/doi/abs/10.1002/cncr.30834.
- Alfaqih MA, Nelson ER, Liu W, Safi R, Jasper JS, Macias E, Geradts J, Thompson JW, Dubois LG, Freeman MR, Chang CY, Chi JT, McDonnell DP, Freedland SJ. CYP27A1 loss dysregulates cholesterol homeostasis in prostate cancer. Cancer Res. 2017 Apr 1;77(7):1662-1673. https://aacrjournals.org/cancerres/article/77/7/1662/625057/CYP27A1-Loss-Dysregulates-Cholesterol-Homeostasis
- Vidal AC, Howard LE, Sun SX, Cooperberg MR, Kane CJ, Aronson WJ, Terris MK, Amling CL, Freedland SJ. Obesity and prostate cancer-specific mortality after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Prostate Cancer Prostatic Dis. 2017;20:72-78. https://www.nature.com/articles/pcan201647.
- Allott EA, Masko EM, Freedland AR, Macias E, Pelton K, Solomon KR, Mostaghel EA, Thomas GV, Pizzo SV, Freeman M, Freedland SJ. Serum cholesterol levels impact tumor progression in a PTEN-deficient transgenic mouse model of prostate cancer. J Urol. 2016 Apr;195(4): Supplement e1144-e1145. https://www.jurology.com/article/S0022-5347(16)02833-0/fulltext.
Contact the Freedland Lab
8631 W. Third St.
Fourth Floor, Suite 430E
Los Angeles, CA 90048